CHATSWORTH, Calif.--(BUSINESS WIRE)--North American Scientific, Inc. (Nasdaq:NASI) today announced that Core Oncology, Inc. has chosen North American Scientific as its exclusive supplier of Palladium (Pd)-103 brachytherapy seeds for use in the soft-tissue brachytherapy market. Core Oncology develops and manufactures brachytherapy delivery techniques and services, and is the third largest domestic supplier of Pd-103 seeds for low dose prostate brachytherapy treatment. As part of the agreement, North American Scientific will supply its Prospera Pd-103 brachytherapy seeds to Core Oncology for global distribution. The agreement has an initial term of three years.
